Medicine Man Technologies to Host Presentation at the 11th Annual LD Micro Main Event on December 5th

DENVER, CO / ACCESSWIRE / November 30, 2018 / Medicine Man Technologies Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), one of the United States’ leading cannabis branding and consulting companies today announced that Brett Roper, Chief Executive Officer, and Andy Williams, Co-Founder and Chairperson of the Board, will be presenting at the LD Micro Conference on December 5, 2018 at 11:30 AM PST / 2:30 PM EST at the Luxe Sunset Bel Air Hotel in Los Angeles, California.

The presentation will be webcast at http://wsw.com/webcast/ldmicro15/mdcl/. An archive of the presentation will also be made available on the Company’s investor relations website.

The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinated evening events.

Mr. Roper and Mr. Williams will be making their corporate presentation on Wednesday, December 5th at 11:30 (Track 3) and have several planned meetings planned throughout the day with various investors and investor groups to discuss the Company’s current as well as future performance and financial needs.

To learn more about the event, please visit: http://www.ldmicro.com/events

To be added to the Medicine Man email distribution list, please email, MDCL@kcsa.com with MDCL in the subject line.

About Medicine Man Technologies, Inc.

Established in March 2014, the Company secured its first client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. The Company currently has or has had active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Oklahoma, Massachusetts, Puerto Rico, Canada, Australia, Germany, South Africa, and New Zealand. We continue to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company’s highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will “share” the ever-improving experience and knowledge of the network, and 5) continuing the expansion of our Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.

Safe Harbor Statement

This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based on many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company’s most recent SEC filings. We have incurred and will continue to incur significant expenses in the expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long-term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

To be added to the Medicine Man email distribution list, please email, MDCL@kcsa.com with MDCL in the subject line.

For more information, visit us at www.medicinemantechnologies.com; www.threealight.com

Contact Information:

Brett Roper via
info@medicinemantechnologies.com
Telephone (303) 371-0387

SOURCE: Medicine Man Technologies Inc. via LD Micro

ReleaseID: 529454